NOIR LEMONI is an emerging player in the personal care industry, founded in 2022. With its headquarters in the United States, the company operates at the intersection of E-Commerce, Health Care, and Health and Wellness.
Their innovative approach features cannabis-derived, lab-tested, and community-approved products, specifically designed to offer pain relief for those suffering from chronic pain conditions. Utilizing cannabinoids such as CBG, CBC, and CBN, these products promise a potent alternative for pain management that aligns with modern wellness trends.
Despite the company’s apparent promise, NOIR LEMONI has yet to receive any external funding, and no recent investments or investor partnerships have been announced. This positions NOIR LEMONI as a potentially lucrative opportunity for investors seeking early-stage ventures in the rapidly growing cannabis and personal care sectors.